Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02192905 · ClinicalTrials.gov registry record · NA
Feasibility Trial of a Problem-Solving Weight Loss Mobile Application
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02192905: Completed NA study, sponsored by University of Connecticut.
NCT02192905 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02192905, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this research was to develop and test the feasibility of Habit, a weight loss mobile application that was designed to coach patients through their weight loss challenges. In a pilot trial in 43 obese participants, investigators tested the feasibility of the Smart Coach mobile application when paired with a shortened online-delivered (8-week) behavioral weight loss intervention. Feasibility outcomes included frequency and duration of usage of the mobile app and each feature, recruitment, and retention. Post-intervention focus groups discussed the feasibility and acceptability of the intervention. The investigators also performed exploratory analyses comparing conditions on problem solving skills and weight loss at 8 and 16 weeks, which will inform a subsequent randomized controlled efficacy trial.
Primary Outcome
Mean total uses of the problem solving function of the mobile application
Interventions
- BEHAVIORAL Diabetes Prevention Program Lifestyle Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT02192905 record still lists
NCT02192905 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Diabetes Prevention Program Lifestyle Intervention is the first listed.
NCT02192905 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02192905 about?
NCT02192905 is a clinical study titled "Feasibility Trial of a Problem-Solving Weight Loss Mobile Application". The purpose of this research was to develop and test the feasibility of Habit, a weight loss mobile application that was designed to coach patients through their weight loss challenges. In a pilot trial in 43 obese participants, investigators tested the feasibility of the Smart Coach mobile applicat...
What is the current status of trial NCT02192905?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2015-12. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02192905?
The interventions under investigation include: Diabetes Prevention Program Lifestyle Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02192905?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02192905's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia